ODC1 and ovarian cancer: CoINcIDE also identified potential druggable targets within each of these meta-clusters, such as the gene ODC1 which has an effect size of 1.092 in meta-cluster 2 (Additional file 1: Table S11) There is not extensive literature on ODC1 in serous ovarian cancer, but it has been suggested that this gene’s expression decreases when platinum is added to ovarian cancer cell lines [36], suggesting ODC1 may indeed have therapeutic relevance for meta-cluster 2.